loader
Please Wait
Applying Filters...
menu
    • menu

    Setid C6754623 B14c 4fc3 8719 48eee3119156 Applno 202513 Form Gel Metered Transdermal Dosage 3 - Drug Product Composition: 4-[bis(1,1,2,2,2-pentadeuterioethyl)amino]but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate

    Menu

    4-[bis(1,1,2,2,2-pentadeuterioethyl)amino]but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 642Xls

    Filters

    clear-filterReset all filters
    SearchXls

    USFDA APPLICATION NUMBER - 202513 / DOSAGE - GEL, METERED;TRANSDERMAL - 3%

    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    OXYBUTYNIN(UNII: K9P6MC7092)
    (OXYBUTYNIN - UNII:K9P6MC7092)     		OXYBUTYNIN28mg in .92

    Inactive Ingredients

    Ingredient Name
    Actavis Pharma, Inc.
    ALCOHOL(3K9958V90M)
    BUTYLATED HYDROXYTOLUENE(1P9D0Z171K)
    DIETHYLENE GLYCOL MONOETHYL ETHER(A1A1I8X02B)
    HYDROCHLORIC ACID(QTT17582CB)
    HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P)
    PROPYLENE GLYCOL(6DC9Q167V3)
    WATER(059QF0KO0R)